Zogenix Inc (ZGNX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

5959 HORTON STREET, SUITE 500 EMERYVILLE, CA 94608

Zogenix, Inc., a pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain.

Data as of 2020-06-06
Market Cap1.659 Billion Shares Outstanding55.341 Million Avg 30-day Volume669.477 Thousand
P/E Ratio Dividend Yield EPS-9.38
Price/Sales338.689 Price cash flow ratio Price free cash flow ratio-11.2
Book Value8.14 Price to Tangible Book4.77 Alpha0.03
Short Interest Ratio % Short Interest to Float R-squared0.056629
BETA1.74317 52-week High/Low57.22 / 16.65 Stddev0.314454
View SEC Filings from ZGNX instead.

View recent insider trading info

Funds Holding ZGNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZGNX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1 Thousand total shares from 1 transactions

Open Market Sells (S)

2.6 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BLAIR JAMES C

  • Director
0 2020-06-04 0

VITULLO NICOLE

  • Director
19,392 2020-05-28 0

RHOADS ANN D

  • Director
0 2020-05-27 0

GARNER CAM L

  • Director
0 2020-05-27 1

KAMDAR KIM P.

  • Director
  • 10% Owner
0 2020-05-12 0

FARFEL GAIL M EVP/CHIEF DEVELOPMENT OFFICER

  • Officer
5,048 2020-05-12 4

SAGROLIKAR ASHISH M EVP & CHIEF COMMERCIAL OFFICER

  • Officer
5,913 2020-05-08 4

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
55,042,456 2020-04-24 0

MITCHELL SHAWNTE EVP, GC AND SECRETARY

  • Officer
0 2020-04-20 2

WIGGINS MARK C

  • Director
2,500 2020-03-23 2

FARR STEPHEN J PRESIDENT AND CEO

  • Officer
  • Director
65,251 2020-03-19 7

GALER BRADLEY S. EVP/CHIEF MEDICAL OFFICER

  • Officer
10,015 2020-03-18 3

BREITMEYER JAMES B CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2020-03-17 2

SMITH MICHAEL P EVP, CFO, TREASURER & SEC.

  • Officer
3,199 2020-03-15 6

DOVEY BRIAN H

  • Director
0 2019-11-11 0

HALAK BRIAN K

  • Director
0 2019-06-19 0

HAWLEY ROGER

  • Director
0 2019-06-13 0

TREU JESSE I

  • Director
0 2019-06-04 0

BOCK LOUIS C

  • Director
0 2019-05-22 0

MAST ERLE T

  • Director
0 2019-05-22 0

TANNENBAUM RENEE P

  • Director
0 2019-05-22 0

WHEELER KURT

  • Director
0 2019-01-22 0

MINOCHERHOMJEE ARDA PHD

  • Director
0 2018-08-13 0

DARCIS THIERRY J.P. EVP / GENERAL MANAGER, EUROPE

  • Officer
0 2017-03-14 0

SHIVELY RICHARD SCOTT SVP & CHIEF COMMERCIAL OFFICER

  • Officer
4,290 2016-04-02 0

SCHOEMAKER KATHLEEN K

  • 10% Owner
No longer subject to file 2014-03-19 0

DP VII ASSOCIATES LP

  • 10% Owner
No longer subject to file 2014-03-19 0

DOMAIN PARTERS VII L P

  • 10% Owner
No longer subject to file 2014-03-19 0

DOMAIN ASSOCIATES

  • 10% Owner
No longer subject to file 2014-03-19 0

DOMAIN PARTNERS VI, L.P.

  • 10% Owner
No longer subject to file 2014-03-19 0

DP VI ASSOCIATES, L.P.

  • 10% Owner
No longer subject to file 2014-03-19 0

CLARUS LIFESCIENCES I, L.P.

CLARUS VENTURES I MANAGEMENT, L.P.

CLARUS VENTURES I, LLC

GALAKATOS NICHOLAS

HENNER DENNIS

LIPTAK ROBERT

SIMON NICHOLAS

STEINMETZ MICHAEL

WHEELER KURT

  • 10% Owner
  • GENERAL PARTNERGP CLARUS VENTURES I MNGMT.MANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GPMANAGING DIR. OF GP
No longer subject to file 2013-09-03 0

ROBINSON CYNTHIA Y CHIEF DEVELOPMENT OFFICER

  • Officer
0 2013-03-15 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • FORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDERFORMER 10% HOLDER
No longer subject to file 2011-09-21 0

CLARUS LIFESCIENCES I, L.P.

CLARUS VENTURES I, LLC

CLARUS VENTURES I MANAGEMENT, L.P.

LIPTAK ROBERT

SIMON NICHOLAS

HENNER DENNIS

GALAKATOS NICHOLAS

STEINMETZ MICHAEL

  • 10% Owner
5,982,439 2010-11-29 0

THOMAS MCNERNEY & PARTNERS LP

THOMAS, MCNERNEY & PARTNERS, LLC

TMP NOMINEE, LLC

TMP ASSOCIATES LP

THOMAS, MCNERNEY & PARTNERS II L.P.

THOMAS, MCNERNEY & PARTNERS II, LLC

TMP NOMINEE II, LLC

TMP ASSOCIATES II LP

THOMAS JAMES E

MCNERNEY PETE

  • SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)SEE FOOTNOTE (10)
No longer subject to file 2010-11-29 0

SCALE VENTURE PARTNERS II, LP

SCALE VENTURE MANAGEMENT II, LLC

BROOKS MARK J

MITCHELL KATE

O'DRISCOLL RORY

WIENBAR SHARON L

  • 10% Owner
4,071,546 2010-11-29 0

HAAS KEN

  • Director
2,335,218 2010-11-29 0

CHICAGO GROWTH PARTNERS II L P

CHICAGO GROWTH MANAGEMENT II, LLC

CHICAGO GROWTH MANAGEMENT II, LP

  • SEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2010-11-29 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

FARFEL GAIL M - Officer EVP/CHIEF DEVELOPMENT OFFICER

2020-05-12 S 2,573 $28.21 d 5,048 5,048.00 direct yes

SAGROLIKAR ASHISH M - Officer EVP & CHIEF COMMERCIAL OFFICER

2020-05-08 P 1,000 $25.45 a 5,913 5,913.00 direct

MITCHELL SHAWNTE - Officer EVP, GC AND SECRETARY

2020-04-20 A 110,000 a 110,000 0.00 direct

Elevate your investments